Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation

被引:18
作者
Usoh, Chinenye O.
Sherazi, Saadia
Szepietowska, Barbara
Kutyifa, Valentina
McNitt, Scott
Papernov, Anna
Wang, Meng
Alexis, Jeffrey D.
机构
[1] Wake Forest Univ, Sch Med, Div Endocrinol & Metab, Winston Salem, NC 27109 USA
[2] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Cardiol Div, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Div Cardiol, Rochester, NY USA
关键词
ADVANCED HEART-FAILURE; RISK-FACTORS; STROKE; IMPACT; IMPROVEMENT; PREVALENCE; PLACEMENT;
D O I
10.1016/j.athoracsur.2018.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite previous studies, the mortality risk of patients with diabetes mellitus after left ventricular assist device (LVAD) implant remains unclear. In addition, the relationship between the degree of glycemic control and long-term mortality risk in LVAD patients with diabetes has not been established. Methods. Ninety-five nondiabetic patients and 96 diabetic patients from the University of Rochester Medical Center who received a HeartMate II (Thoratec, Pleasanton, CA) continuous-flow LVAD between May 2008 and June 2014 were included in this study. The primary outcome was all-cause mortality. Secondary outcomes included rates of infection, neurologic dysfunction, renal dysfunction, and rehospitalization. Kaplan-Meier survival analyses and Cox models were utilized. Results. During follow-up, 32 diabetic patients (33%) and 15 nondiabetic patients (16%) died after LVAD implantation. Cumulative probability of death was higher for diabetic patients when compared with nondiabetic patients (42% versus 21% at 3 years, p = 0.013). There were no significant differences in overall rates of infection, neurologic dysfunction, and rehospitalization between the two groups. However, after an initial secondary outcome event, diabetic patients continued to have a higher mortality rate when compared with nondiabetic patients. There was no statistically significant difference in the risk of death between diabetic patients with pre-LVAD hemoglobin A1c less than 7.0% and diabetic patients with pre-LVAD hemoglobin A1c 7.0% or greater (hazard ratio 1.71, 95% confidence interval: 0.72 to 4.08, p = 0.223). Conclusions. Diabetic patients who underwent LVAD implantation had a higher risk of death compared with nondiabetic patients. Adverse event rates did not differ between the two groups. Finally, the degree of glycemic control in diabetic patients before LVAD was not found to influence mortality. (C) 2018 by The Society of Thoracic Surgeons
引用
收藏
页码:555 / 560
页数:6
相关论文
共 20 条
  • [1] Novel metabolic risk factors for incident heart failure and their relationship with obesity
    Bahrami, Hossein
    Bluemke, David A.
    Kronmal, Richard
    Bertoni, Alain G.
    Lloyd-Jones, Donald M.
    Shahar, Eyal
    Szklo, Moyses
    Lima, Joao A. C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (18) : 1775 - 1783
  • [2] Impact of diabetes mellitus on cardiac surgery outcome
    Bucerius, J
    Gummert, JF
    Walther, T
    Doll, N
    Falk, V
    Onnasch, JF
    Barten, MJ
    Mohr, FW
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2003, 51 (01) : 11 - 16
  • [3] Diabetes and outcomes after left ventricular assist device placement
    Butler, J
    Howser, R
    Portner, PM
    Pierson, RN
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (07) : 510 - 515
  • [4] Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure
    Chokshi, Aalap
    Drosatos, Konstantinos
    Cheema, Faisal H.
    Ji, Ruiping
    Khawaja, Tuba
    Yu, Shuiqing
    Kato, Tomoko
    Khan, Raffay
    Takayama, Hiroo
    Knoell, Ralph
    Milting, Hendrik
    Chung, Christine S.
    Jorde, Ulrich
    Naka, Yoshifumi
    Mancini, Donna M.
    Goldberg, Ira J.
    Schulze, P. Christian
    [J]. CIRCULATION, 2012, 125 (23) : 2844 - +
  • [5] Improvement in Glycemic Control After Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients With Diabetes Mellitus
    Choudhary, Naila
    Chen, Leway
    Kotyra, Lisa
    Wittlin, Steven D.
    Alexis, Jefrey D.
    [J]. ASAIO JOURNAL, 2014, 60 (06) : 675 - 680
  • [6] Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
    Dei Cas, Alessandra
    Khan, Sadiya S.
    Butler, Javed
    Mentz, Robert J.
    Bonow, Robert O.
    Avogaro, Angelo
    Tschoepe, Diethelm
    Doehner, Wolfram
    Greene, Stephen J.
    Senni, Michele
    Gheorghiade, Mihai
    Fonarow, Gregg C.
    [J]. JACC-HEART FAILURE, 2015, 3 (02) : 136 - 145
  • [7] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [8] Diabetes in heart failure: Prevalence and impact on outcome in the population
    From, Aaron M.
    Leibson, Cynthia L.
    Bursi, Francesca
    Redfield, Margaret M.
    Weston, Susan A.
    Jacobsen, Steven J.
    Rodeheffer, Richard J.
    Roger, Veronique L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (07) : 591 - 599
  • [9] Improvement in Blood Glucose Control in Patients With Diabetes After Implantation of Left Ventricular Assist Devices
    Guglin, Maya
    Maguire, Kim
    Missimer, Taylor
    Faber, Cristiano
    Caldeira, Christiano
    [J]. ASAIO JOURNAL, 2014, 60 (03) : 290 - 293
  • [10] Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era
    Harvey, Laura
    Holley, Christopher
    Roy, Samit S.
    Eckman, Peter
    Cogswell, Rebecca
    Liao, Kenneth
    John, Ranjit
    [J]. ANNALS OF THORACIC SURGERY, 2015, 100 (02) : 535 - 541